BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF

BioVaxys Technology (BVAXF) Stock Price & Analysis

29 Followers

BVAXF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.08
Previous Close$0.05
Volume918.78K
Average Volume (3M)105.69K
Market Cap
$9.30M
Enterprise Value$10.36M
Total Cash (Recent Filing)$423.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)
Beta2.12
Sep 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding148,014,057
10 Day Avg. Volume51,830
30 Day Avg. Volume105,693
Standard Deviation0.87
R-Squared0.08
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)-11.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-109.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

14.12%0.00%<0.01%85.88%
14.12% Insiders
<0.01% Other Institutional Investors
85.88% Public Companies and
Individual Investors

BVAXF FAQ

What was BioVaxys Technology’s price range in the past 12 months?
BioVaxys Technology lowest stock price was <$0.01 and its highest was $0.07 in the past 12 months.
    What is BioVaxys Technology’s market cap?
    Currently, no data Available
    When is BioVaxys Technology’s upcoming earnings report date?
    BioVaxys Technology’s upcoming earnings report date is Sep 26, 2024 which is in 63 days.
      How were BioVaxys Technology’s earnings last quarter?
      BioVaxys Technology released its earnings results on Jul 10, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
        Is BioVaxys Technology overvalued?
        According to Wall Street analysts BioVaxys Technology’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BioVaxys Technology pay dividends?
          BioVaxys Technology does not currently pay dividends.
          What is BioVaxys Technology’s EPS estimate?
          BioVaxys Technology’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does BioVaxys Technology have?
          BioVaxys Technology has 220,241,650 shares outstanding.
            What happened to BioVaxys Technology’s price movement after its last earnings report?
            BioVaxys Technology reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of BioVaxys Technology?
              Currently, no hedge funds are holding shares in BVAXF
              ---

              BioVaxys Technology Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              212.50%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -34.27%
              Trailing 12-Months

              Company Description

              BioVaxys Technology

              Lions Bay Mining Corp is a Canada based mineral exploration company. The company currently retains five mineral properties, with four in the Yukon Canada and one in Nevada. The Yukon properties include the, HY Jay, VM, VBA and Big properties and the Nevada property is located at Fish Lake in Esmeralda County.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              BiomX
              Oncolytics Biotech
              CytoDyn
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis